Planet 13 Holdings (Planet 13 Holdings) Risk Assessment

View and export this data going back to 2018. Start your Free Trial

What is Planet 13 Holdings Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Planet 13 Holdings is: High Risk: High uncertainty.

Competitive Comparison of Planet 13 Holdings's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Planet 13 Holdings's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Planet 13 Holdings's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Planet 13 Holdings's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Planet 13 Holdings's Risk Assessment falls into.

Planet 13 Holdings (OTCPK:PLNH) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Planet 13 Holdings Risk Assessment Related Terms

Thank you for viewing the detailed overview of Planet 13 Holdings's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Planet 13 Holdings (Planet 13 Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Planet 13 Holdings Inc (OTCPK:PLNH) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

PLTH:Canada

Address

2548 West Desert Inn Road, Las Vegas, NV, USA, 89109

Website

https://www.planet13holdings.com

Planet 13 Holdings Inc operates as an integrated cannabis company based in Nevada, with cultivation, production, and dispensary operations in Las Vegas. The company is focused on providing an unparalleled dispensary experience and optimizing cultivation efficiencies through its technology as the vanguard of cannabis.

Executives

Chris Wren	officer: VP of Operations	2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Dennis Logan	officer: CFO	2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Leighton Koehler	officer: General Counsel	2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Larry Scheffler	director, 10 percent owner, officer: Co-CEO	2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
David Farris	officer: VP of Sales & Marketing	2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Adrienne O'neal	director	2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
William Vargas	officer: VP of Finance	2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Robert Groesbeck	director, 10 percent owner, officer: Co-CEO	2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Lee Fraser	director	4675 W TECO AVE, SUITE 250, LAS VEGAS NV 89118
Todd Hybels	officer: VP of Midwestern Operations	2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Michael Lanteri Jennings	officer: Pres. of East Coast Operations	2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Michael Harman	director	2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109